References
- Rathore AS, Winkle H. Quality by design for biopharmaceuticals. Nature Biotech 2009; 27:26-34; http://dx.doi.org/10.1038/nbt0109-26
- Kozlowski S, Swann P. Current and future issues in the manufacturing and development of monoclonal antibodies. Adv Drug Deliv Rev 2006; 58:707-722; PMID:16828921; http://dx.doi.org/10.1016/j.addr.2006.05.002
- Martin-Moe S, Lim FJ, Wong RL, Sreedhara A, Sundaram J, Sane SU. A new roadmap for biopharmaceutical drug product development: Integrating development, validation, and quality by design. J Pharm Sci 2011; 100:3031-3043; PMID:21425164; http://dx.doi.org/10.1002/jps.22545
- Rathore AS. Roadmap for implementation of quality by design (QbD) for biotechnology products. Trends Biotechnol 2009; 27:546-553; PMID:19647883; http://dx.doi.org/10.1016/j.tibtech.2009.06.006
- International Conference of Harmonisation (ICH) Harmonised Tripartite Guideline: Q8(R1-R2) Pharmaceutical Development. 2008. Available at: www.ich.org/products/guidelines/quality/article/quality-guidelines.html
- International Conference of Harmonisation ICH Harmonised Tripartite Guideline: Q9 Quality Risk Management. 2005. Available at: www.ich.org/products/guidelines/quality/article/quality-guidelines.html
- International Conference of Harmonisation ICH Harmonised Tripartite Guideline: Q10 Pharmaceutical Quality Systems. 2008. Available at: www.ich.org/products/guidelines/quality/article/quality-guidelines.html
- International Conference of Harmonisation ICH Harmonised Tripartite Guideline: Q11 Development and manufacture of drug substances (chemical entities and biotechnological/biological entities). 2012. Available at: www.ich.org/products/guidelines/quality/article/quality-guidelines.html
- EMA and FDA extend pilot programme for parallel assessment of quality-by-design applications. 2014. Available at: http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2014/03/news_detail_002035.jsp&mid=WC0b01ac058004d5c1
- European Medicines Agency (EMA). European public assessment report for Perjeta. 2013. Available at: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/002547/WC500141004.pdf
- Shade K-T C, Anthony RM. Antibody glycosylation and inflammation. Antibodies 2013; 2:392-414; http://dx.doi.org/10.3390/antib2030392
- European Medicines Agency (EMA). european public assessment report for Gazyvaro. 2014. Available at: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/002799/WC500171596.pdf